Call

Another Look Finds Promising Proteomics Test is Not Biologically Plausible

In a new study, researchers present a “cautionary tale?about what may go wrong when using the fledgling science of proteomics to devise a diagnostic test for cancer. In the February 16 issue of the Journal of the National Cancer Institute, researchers from The University of Texas M. D. Anderson Cancer Center detail why an experimental test intended to identify early ovarian cancer from a...

Genetically modified natural killer immune cells attack, kill leukemia cells

Natural killer (NK) immune system cells can be genetically modified to brandish a powerful "on-switch" that prompts them to aggressively attack and kill leukemic cells. This finding, from researchers at St. Jude Children's Research Hospital, suggests a way to improve the outcome of children who receive treatment for acute lymphoblastic leukemia (ALL) or other blood cancers. Results of the...

NYC's First Rapid HIV Drug-resistant AIDS Case Prompts Call to Step Up HIV Prevention

New York City's Public Health Department today issued a public health advisory after reporting the first documented case of an alarming, new, rapidly-progressing and highly drug resistant strain of HIV in a New York man who progressed from his initial HIV infection, thought to have occurred in mid-October 2004, to a largely untreatable strain of AIDS in just three months. According to City...

Genetically modified rice in China benefits farmers' health, study finds

Farmers growing genetically modified rice in field trials in China report higher crop yields, reduced pesticide use and fewer pesticide-related health problems, according to a study by researchers in China and at Rutgers University and the University of California, Davis. "This paper studies two of the f...

DuPont's first biologically derived polymer receives global recognition

DuPont's newest polymer innovation, the first DuPont polymer derived from a biological source, has been recognized by the China State Intellectual Property Office and China Central Television (CCTV) as "Most Visionary Innovation" at a recent award ceremony. will receive the 2005 "New Technologies in Re...

More>>

Call at Biology Products

Zero Blunt TOPO PCR Cloning Kit with One Shot TOP10 Chemically Competent E. coli from Invitrogen

Description:The Zero Blunt TOPO PCR Cloning Kit offers the fastest and easiest method for high-efficiency (greater than or equal to95%) cloning of blunt-end PCR products amplified with proofreading thermostable polymerases. The kit includes the linearized and topoisom...
Company:Invitrogen

Zero Blunt TOPO Kit for Sequencing with One Shot Mach1 T1 Phage-Resistant Chemically Competent E. coli from Invitrogen

Description:The TOPO Cloning Kits for Sequencing allow 5-minute cloning and subsequent sequencing of PCR products. The kits contain TOPO Cloning vectors with primer sites located as close as 33 base pairs from the PCR product insertion site. This minimizes the amount of vector DNA that needs to be read before reaching the sequence of your insert.vectors are available. The pCR4-TOPO vector provides 3-T overha...
Company:Invitrogen

Zero Blunt TOPO PCR Cloning Kit with One Shot Mach1 T1 Phage-Resistant Chemically Competent E. coli from Invitrogen

Description:The Zero Blunt TOPO PCR Cloning Kit offers the fastest and easiest method for high-efficiency (>=95%) cloning of blunt-end PCR products amplified with proofreading thermostable polymerases. The kit includes the linearized and topoisomerase I-activated pCR-Blunt II-TOPO vector for 5-minute bench-top ligations without ligase (1). The pCR-Blunt II-TOPO vector also features:...
Company:Invitrogen

GIBCO Chemically Defined Lipid Concentrate from Invitrogen

Description:Chemically Defined Lipid Concentrate...
Company:Invitrogen

One Shot INVAlphaF' Chemically Competent E. coli from Invitrogen

Description:Request Info...
Company:Invitrogen

More>>

Call at Biology Technology

Production of Full-Length, Biologically Active MEK1WT and MEK1CA

Stratagene Cloning Systems, Inc. Stratagene has successfully expressed and purified recombinant, wild-typehuman MEK1 )using the ESP yeast pro...

Cell Proliferation Kit Outperforms the Competition in the Range of Cells Typically Counted

Quantitating cell number is more accurate using the Quantos cellproliferation assay kit Genetic Applications LLC cell proliferation assay kitprovides a simple, reproducible method to assess the number of cells present invarious tissue culture dish formats. In this st...

Kanavas calls for audit of data security practices

In the letter, addressed to <a h...

Calling all computers: VoIP goes mainstream

Chances are you have already received phone calls that spent part of their time on the Internet, thanks to a technology that has finally crossed into the mainstream. And if your company isnt already making use of the Internet to carry phone calls, it will probably consider doing so sooner rather tha...

CPM Helps Physicians Group Retain Patients with New Kind of House Call

Middleton, WI Combining database and personalized print technology, a physicians group in the Midwest is making a new kind of house call to retain patients. Instead of waiting for patients to come to their offices for treatment, these physicians are sending personalized messages by mail with reminders for important check-ups and screenings -- and seeing response rates of 10 to 21 percent. <b...

More>>

Call at Medicine News

Right drugs drastically cut stroke risk

In the biggest breakthrough, the incidence of the disease was found to have been cut to half by a combination of drugs that keeps blood pressure in check. The study involving about 6,000 patients over six years in many countries showed that strokes were cut by at least a quarter among patients given the drugs. // The drugs are inexpensive and easily available. Use of the drugs cut b...

Women find difficulty in calling it 'Quits'

A review of numerous research studies focusing on smoking cessation has concluded that while women may suffer greater relative risks of smoking-related diseases than do men, they tend to have less success than men in quitting smoking. Dr. Kenneth A. Perkins from the University of Pittsburgh School of Medicine who conducted the review offers several reasons for this disparity in a paper pu...

Emotional callers hamper speedy ambulance dispatch

People's lives are being put at risk because emergency call-takers are not adequately trained to deal with emotional callers, according to a recent study. Callers unable to communicate properly because of their emotional state caused the most difficulties but problems were also caused by people using mobile phones or pay-phones as opposed to land-lines. // The study, carried out by t...

Women call for health right to rural women

Indian Policy makers and women rights activists have stressed the need for more concrete steps to improve women's access to quality // healthcare services in the country. In a unique initiative, the Women’s Health Rights Advocacy Partnership (WHRAP), a South Asian forum, brought the grassroots women workers on a common platform in the Capital last week, where these women shared their e...

Wake-up call for peripheral artery disease

Peripheral artery disease is underdiagnosed and treated in many cases, say US doctors. In peripheral artery disease (PAD), the arteries in the legs and arms become blocked with the same kind of fatty deposits - plaque - which cause coronary artery disease. The best way of treating it is very simple - keep walking. While the disease makes walking painful, regular exercise does actually inc...

More>>

Call at Medicine Products

SDS Patient Recall

Description:The SDS Recall marketing software enables the efficient capture of lifestyle, demographics and clinical information. The module also has many built-in time saving and error checking devices such as: auto capitalization of name fields and numerous user definable pop up tables ensuring consistent and accurate data input. The pre-defined options in the pop up tables means that the user simply has to...
Company:Special Data Solutions

WET-FIELD Diathermy Coagulator (universal power supply for 100-240 volts) w/footswitch - electrically powered

Description:The Wet-Field Coagulator provides precise episcleral, intrascleral, and intraocular hemostasis with reduced peripheral tissue trauma. Controlled Rf diathermy delivers targeted coagulation with the most comprehensive line of bipolar Eraser instruments, forceps and cables. This instrument combines enhanced features that ensure a high level of Wet-Field safety and operational effiiciency....
Company:Medtronic Xomed, Inc.

WET-FIELD Diathermy Coagulator w/Harmonized Power Cord (universal power supply for 100-240 volts) and footswitch - electrically powered

Description:The Wet-Field Coagulator provides precise episcleral, intrascleral, and intraocular hemostasis with reduced peripheral tissue trauma. Controlled Rf diathermy delivers targeted coagulation with the most comprehensive line of bipolar Eraser instruments, forceps and cables. This instrument combines enhanced features that ensure a high level of Wet-Field safety and operational effiiciency....
Company:Medtronic Xomed, Inc.

First-Call Medical Monitoring Services

Description:First-Call Medical, Nationwide 24-Hour Holter, Event, and Pacemaker Monitoring. First-Call Medical is a cardiac scanning laboratory located in Billerica, MA. The laboratory offers the finest diagnostic equipment to assist physicians in the assessment and treatment of the cardiac patient. The diagnostic services are offered nationwide by employing the latest reporting technologies via fax and on-l...
Company:First Call Medical, Inc.

ThermalSeal RT Optically Clear Adhesive Plate Film (2mil)

Description:ThermalSeal RT (2mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates....
Company:MIDSCI

More>>

Call at Medicine Technology

Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycin's First of Two Phase 3 Pneumonia Trials

CHICAGO, June 29, 2007 /PRNewswire-FirstCall/ -- Advanced LifeSciences Holdings, Inc. , today announced that it will host aconference call and live webcast at 10:00 am (EDT) on Monday, July2, 2007 to discuss data from Trial CL-06, the first of two pivotalPhase 3 clinical trials designed to assess the safety andeffectiveness of cethromycin, a novel once-a-day antibiotic, forthe treatment...

Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos

New survey shows more than half of infertile couples willing todonate unused embryos for stem cell research BETHESDA, Md., June 20, 2007 /PRNewswire/ -- RESOLVE: TheNational Infertility Association issued the following statementtoday, in anticipation of President Bush's veto of federallegislation that would loosen current limitations on stem cellresearch: "President Bush is choosin...

Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease

FORT LEE, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Neurologix, Inc.(OTCBB:NRGX) today announced the publication in the June 23 issueof the journal The Lancet of positive results from the first evergene therapy trial for Parkinson's disease and the first report ofdirect gene transfer into a patient's own brain cells for any adultneurodegenerative disease. The open label Phase 1 study, conduct...

Medivation's Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimer's Disease Trial After One Year of Therapy

- Aggregate Benefit over Placebo Larger at One Year than at SixMonths - SAN FRANCISCO and WASHINGTON, June 11, 2007/PRNewswire-FirstCall/ -- Medivation, Inc. today announced that thebenefits of Dimebon over placebo in its double-blind,placebo-controlled Phase 2 study in mild-to- moderate Alzheimer'sdisease were statistically significant on all five study endpointsat 12 months. Importantl...

Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimer's Disease Study

SAN FRANCISCO, June 05, 2007 /PRNewswire-FirstCall/ --Medivation, Inc. today announced that it will hold a teleconferenceat 8:30 a.m. Eastern time on Monday, June 11, to discuss top-line12-month results from its randomized, double-blind,placebo-controlled Phase 2 clinical trial of Dimebon(TM), its leadproduct candidate, in Alzheimer's disease. Rachelle Doody, M.D., Ph.D., lead inve...

More>>

Call at Medicine Dictionary

Corns and calluses

-shaped w...

Callus

<A href="http:/ / www.medicinenet.com/ script/ main/ art.asp?a...